SENTIEN BIOTECHNOLOGIES

sentien-biotechnologies-logo

Sentien Biotechnologies is a privately-owned, clinical-stage company developing novel cell therapies that restore balance to the immune system and transform treatment options for patients with systemic inflammatory diseases. The company's innovative blood conditioning approach has been proven to significantly enhance exposure and extend therapeutic activity of Mesenchymal Stromal Cells (MSCs). By immobilizing MSCs in an extracorporeal device, their flagship SBI-101 product enables sustained, controlled dosage of secreted anti-inflammatory and regenerative properties that are unattainable by direct injection or intravenous infusion. Sentien Biotechnologies was established in 2008 and is headquartered in Lexington, Massachusetts, United States.

#SimilarOrganizations #People #Financial #Event #Website #More

SENTIEN BIOTECHNOLOGIES

Social Links:

Industry:
Biotechnology Health Care Therapeutics

Founded:
2008-01-01

Address:
Lexington, Massachusetts, United States

Country:
United States

Website Url:
http://www.sentienbiotech.com

Total Employee:
1+

Status:
Active

Contact:
781-361-9031

Email Addresses:
[email protected]

Total Funding:
15.13 M USD

Technology used in webpage:
Google Apps For Business Gravity Forms 1and1


Similar Organizations

adamas-pharmaceuticals-logo

Adamas Pharmaceuticals

Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.


Current Advisors List

johannes-fruehauf_image

Johannes Fruehauf Board Director @ Sentien Biotechnologies
Board_member
2016-01-01

martin-heidecker_image

Martin Heidecker Board of Directors @ Sentien Biotechnologies
Board_member
2015-08-01

Current Employees Featured

richard-ganz_image

Richard Ganz
Richard Ganz Chairman & Board of Directors @ Sentien Biotechnologies
Chairman & Board of Directors
2008-05-01

allen-nissenson_image

Allen Nissenson
Allen Nissenson Chief Medical Officer @ Sentien Biotechnologies
Chief Medical Officer
2020-07-01

brian-miller_image

Brian Miller
Brian Miller CEO, Co-Founder & Board of Directors @ Sentien Biotechnologies
CEO, Co-Founder & Board of Directors
2008-03-01

biju-parekkadan_image

Biju Parekkadan
Biju Parekkadan Scientific Co-Founder & Board of Directors @ Sentien Biotechnologies
Scientific Co-Founder & Board of Directors
2008-11-01

Founder


biju-parekkadan_image

Biju Parekkadan

brian-miller_image

Brian Miller

Investors List

chiesi-ventures_image

Chiesi Ventures

Chiesi Ventures investment in Series A - Sentien Biotechnologies

bioinnovation_image

BioInnovation

BioInnovation investment in Series A - Sentien Biotechnologies

mass-medical-angels_image

Mass Medical Angels

Mass Medical Angels investment in Series A - Sentien Biotechnologies

boehringer-ingelheim-venture-fund_image

Boehringer Ingelheim Venture Fund

Boehringer Ingelheim Venture Fund investment in Series A - Sentien Biotechnologies

mbl-venture-capital_image

MBLVC

MBLVC investment in Series A - Sentien Biotechnologies

Official Site Inspections

http://www.sentienbiotech.com Semrush global rank: 3.54 M Semrush visits lastest month: 4.14 K

  • Host name: 104.21.48.1
  • IP address: 104.21.48.1
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Sentien Biotechnologies"

Sentien Biotechnologies - Crunchbase Company โ€ฆ

Contact Email [email protected] Phone Number 781-361-9031 Sentien Biotechnologies is a privately-owned, clinical-stage company developing โ€ฆSee details»

Sentien Biotech - The Org

Sentien Biotechnologies, Inc. is a privately owned, clinical-stage company developing novel approaches to cell therapy. Sentienโ€™s mission is to harness the power of cell therapy with innovative drug delivery systems to treat a wide โ€ฆSee details»

Sentien Biotechnologies, Inc. - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Sentien Biotechnologies, Inc. of Lexington, MA. Get the latest business insights from Dun & Bradstreet.See details»

Sentien Biotechnologies, Inc. Management Team | Org Chart

Sentien Biotechnologies, Inc. employs 12 employees. The Sentien Biotechnologies, Inc. management team includes Brian Miller (Chief Executive Officer, Co-Founder), Rich Ganz โ€ฆSee details»

Org Chart Sentien Biotech - The Official Board

Organizational Chart of Sentien Biotech. Sentien Biotech www.sentienbiotech.com. has 8 executives - and belongs to Portage Biotech +1 781 361 9031; Add an executive. Sentien โ€ฆSee details»

Sentien Company Profile 2024: Valuation, Funding

Nov 19, 2017 Sentien General Information Description. Operator of a clinical-stage biotechnology company intended to treat patients suffering from a dysregulated immune system. The company helps to restore balance to the โ€ฆSee details»

Sentien Biotechnologies, Inc. Information - RocketReach

What is the annual revenue of Sentien Biotechnologies, Inc.? The Sentien Biotechnologies, Inc. annual revenue was $13 million in 2024.See details»

Sentien Biotechnologies - Products, Competitors, Financials, โ€ฆ

Headquarters Location. 99 Hayden Avenue Building E, Suite 140. Lexington, Massachusetts, 02421, United States +1-781-361-9031See details»

Sentien Biotechnologies - Overview - aiHit

Sentienbiotech.com; [email protected] +1-781-361-9031; clinical-stage; CLICK HERE TO SEE DETAILS OF COMPANY CHANGES. Sentien Biotechnologies, Inc. is a privately-owned, โ€ฆSee details»

Sentienbiotech - CoBee Company Profile & Funding Rounds

Sentienbiotech. Sentien is a biotechnology firm developing cell-based blood conditioning therapies to restore balance to the immune systems of critically ill patients. Business Model: โ€ฆSee details»

Overview, News & Similar companies - ZoomInfo.com

Mar 29, 2021 www.sentienbiotech.com. Revenue <$5 Million. Industry Business Services General Business Services . Recent News & Media. Sentien Biotechnologies Partners with โ€ฆSee details»

Sentien Biotechnologies, Inc. - Drug pipelines, Patents, Clinical ...

Explore Sentien Biotechnologies, Inc. with its drug pipeline, therapeutic area, technology platform, 2 clinical trials, 6 news, and 8 literature, Drug:SBI-101 (Sentien Biotechnologies).See details»

Sentien Biotechnologies - Craft

Sentien Biotechnologies has 5 employees at their 1 location and $15.1 m in total funding,. See insights on Sentien Biotechnologies including office locations, competitors, revenue, financials, โ€ฆSee details»

SENTIEN BIOTECHNOLOGIES, INC. - VentureRadar

Website: http://www.sentienbiotech.com. Develops cell-based therapies for critical care, focusing on treating Acute Kidney Injury, and has received multiple NIH ...See details»

Sentien Biotechnologies, Inc. | LinkedIn

Sentien Biotechnologies, Inc. | 1,371 followers on LinkedIn. Restoring Balance to the Immune System | Sentienโ€™s mission is to harness the power of cell therapy with innovative drug โ€ฆSee details»

Sentien Biotechnologies: Employee Directory | ZoomInfo.com

Sentien Biotechnologies Contact Info: Phone number: (781) 361-9031 Website: www.sentienbiotech.com What does Sentien Biotechnologies do? Sentien Biotechnologies, โ€ฆSee details»

Sentien Biotechnologies Company Profile - MedTech Innovator

Sentien Biotechnologies, Inc., a clinical-stage biotechnology company developing novel approaches to cell therapy, today announced it has completed enrollment of the first cohort in โ€ฆSee details»

Sentien Biotechnologies - MSCRF

Sentien Biotechnologies, Inc. is a privately-owned, clinical-stage company developing novel cell therapies that restore balance to the immune system and transform treatment options for โ€ฆSee details»

Sentien Biotechnologies, Inc. HR Department | Sentien โ€ฆ

Sentien Biotechnologies, Inc. employs 11 employees. The Sentien Biotechnologies, Inc. management team includes Brian Miller (Chief Executive Officer, Co-Founder), Rich Ganz โ€ฆSee details»

Sentien Biotechnologies Announces First Subject Dosed in Phase โ€ฆ

[email protected] 781.361.9031 www.sentienbiotech.com Sentien Biotechnologies Announces First Subject Dosed in Phase 1/2 Trial of Ex Vivo MSC Therapy for the Treatment โ€ฆSee details»

linkstock.net © 2022. All rights reserved